News & Updates
Articles, Updates
Driven to Find a Diagnosis and Treatment: Toby’s CIDP Story
In 2016, before he turned 45, Toby Orcutt realized he could no longer drive.
Articles, Research
Mizzou Researchers Uncover Promising New Target for Treating High Blood Pressure
Discovery could lead to more precise treatments by reducing inflammation linked to hypertension.
Articles, Research
Mizzou Researcher Leading the Way in Search of First-Ever Treatment for Common Heart Valve Disease
Dunpeng Cai received a $2.8 million NIH grant to study the underlying causes of aortic valve calcification and find a target for treatment.
Events
Clinical Research Study Coordinator Bootcamp: September 11, 2026
A full day training designed to provide basic knowledge that is beneficial for research coordinators and staff. The program includes lectures, interactive activities, and breakout group exercises.
Cardiovascular, Muscle & Metabolism Science Seminar: September 14, 2026
"New Insights into Muscle Insulin Resistance: From Outside to Inside the Myocyte,” presented by Nathan Winn, September 14 at 12pm
Neuroscience Seminar: September 14, 2026
"Investigating Stress as a Risk Factor for Neurodegenerative Disease,” presented by Dr. Daryl Bosco, PhD, September 14 at 4pm
Researchers
NextGen Precision Health investigators and their lab teams are dedicated to delivering the next generation of personalized health care solutions. They’ve been recruited from around the world to align their efforts across disciplines in pursuit of improved health outcomes for Missourians and beyond.
World-class research spaces
The Roy Blunt NextGen Precision Health building accelerates innovations in precision health care for Missourians and the world.
A System of Strengths
Mizzou, the University of Missouri–Kansas City, Missouri University of Science and Technology and the University of Missouri–St. Louis each have unique research focuses and resources contributing to the NextGen Precision Health initiative. Working with University of Missouri Health Care, MU Extension and private partners, researchers are exploring precision health solutions for society's toughest diseases.
